Biodexa Pharmaceuticals Plc (LON:MTPH – Get Free Report) passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 18 ($0.23) and traded as low as GBX 12.50 ($0.16). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.23), with a volume of 73,672 shares.
Biodexa Pharmaceuticals Stock Performance
The firm has a market cap of £31.20 million, a P/E ratio of -21.95 and a beta of 1.22. The company has a debt-to-equity ratio of 9.52, a quick ratio of 5.28 and a current ratio of 5.28. The firm has a fifty day moving average of GBX 18 and a 200-day moving average of GBX 18.
About Biodexa Pharmaceuticals
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection.
Further Reading
- Five stocks we like better than Biodexa Pharmaceuticals
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 3 Value Stocks Too Small For Buffett’s Portfolio
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- Dividend Tax Calculator
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Biodexa Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biodexa Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.